Cytokines, viruses, and other bio-factors can lead to phosphorylation of PI3K and AKT [14], which can activate NF-κB, and the PI3K/Akt/NF-κB signal pathway can become a target for treatment of CID or screening drugs. Here, NFKB1 is linked to combined immunodeficiency.